You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 45 An integrative immune signature of complementary circulating and tumoral biomarkers maximizes the predictive power of adjuvant immunotherapeutic benefits for high-risk melanoma

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
45 An integrative immune signature of complementary circulating and tumoral biomarkers maximizes the predictive power of adjuvant immunotherapeutic benefits for high-risk melanoma

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 202325807
Dec 20236105
Jan 20242805
Feb 20245605
Mar 20244802
Apr 20243401
May 20241801
Jun 20243003
Jul 20243406
Aug 20243405
Sep 20242803
Oct 20243406
Nov 202420013
Dec 20242204
Jan 20257104
Feb 2025805
Mar 2025009
Apr 2025007
May 2025006
Jun 2025005
Total7840102